Akebia Therapeutics, Inc. Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 96.26%-1,353.36%-0.62%28.81%70.74%-641.49%60.56%
EBT Margin -8,843.45%-40.65%-82.76%-2,862.90%-130.61%-133.25%-32.22%-519.25%-43.33%
EBIT Margin -8,889.90%-42.31%-85.76%-2,862.88%-128.23%-124.97%-27.62%-462.56%-31.51%
EBITDA Margin -8,846.19%-40.87%-69.03%-2,793.98%-130.61%-133.25%-32.22%-519.25%-43.33%
Operating Margin -8,889.90%-42.31%-85.76%-2,862.88%-128.23%-124.97%-27.62%-462.56%-31.51%
Net Margin -8,843.45%-40.65%-69.12%-2,796.59%-130.61%-133.25%-32.22%-519.25%-43.33%
FCF Margin 3,598.96%-31.88%-47.70%-2,640.96%-37.57%-119.55%-25.05%-233.84%-25.40%
Efficiency
Inventory Average 115.30M88.68M48.82M29.10M18.63M15.97M
Assets Average 332.23M680.39M883.87M707.67M586.74M442.70M298.88M231.19M
Equity Average 95.35M379.25M515.34M319.56M159.18M39.62M-12.68M-39.88M
Invested Capital 68.12M122.57M650.93M394.76M340.73M171.55M71.31M4.10M-10.49M
Asset Utilization Ratio 0.550.310.010.420.360.660.030.69
Leverage & Solvency
Debt to Equity 0.020.190.391.3212.63-1.13-0.79
Debt Ratio 0.020.100.150.180.190.140.18
Equity Ratio 0.230.340.640.510.380.140.01-0.13-0.22
Valuation
Enterprise Value 137.66M457.93M52.57M640.55M176.01M245.61M15.68M190.68M362.67M
Market Capitalization 398.00M702.89M315.54M788.24M404.71M395.41M106.15M233.60M414.54M
Return Ratios
Return on Sales -88.43%-0.41%-0.69%-27.97%-1.31%-1.33%-0.32%-5.19%-0.43%
Return on Capital Employed -0.40%-0.43%-0.42%-0.73%-0.81%-0.26%-0.23%-0.34%
Return on Invested Capital -0.38%-0.53%
Return on Assets -0.22%-0.21%-0.32%-0.54%-0.48%-0.21%-0.17%-0.30%
Return on Equity -0.77%-0.38%-0.54%-1.20%-1.77%-2.38%4.10%1.74%